Capital Research Global Investors Evolent Health, Inc. Transaction History

Capital Research Global Investors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$7.71 - $14.54 $38.2 Million - $72.1 Million	-4,957,412 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$12.17 - $20.92 $32.7 Million - $56.2 Million	-2,684,725 Reduced 35.13%	4,957,412 $62.4 Million
Q4 2018 Feb 14, 2019	SELL	$17.75 - $27.2 $1,029 - $1,577	-58 Reduced -0.0%	7,642,137 $152 Million
Q3 2018 Nov 14, 2018	BUY	$20.1 - $28.75 $5.79 Million - $8.29 Million	288,195 Added 3.92%	7,642,195 $217 Million
Q2 2018 Aug 14, 2018	SELL	$13.8 - $23.95 $21.6 Million - $37.5 Million	-1,564,515 Reduced 17.54%	7,354,000 $155 Million
Q1 2018 May 15, 2018	BUY	$12.8 - $16.5 $13.2 Million - $17 Million	1,029,515 Added 13.05%	8,918,515 $127 Million
Q4 2017 Feb 14, 2018	BUY	$10.5 - $18.7 $82.8 Million - $148 Million	7,889,000	7,889,000 $97 Million

298

127M

2.03M

1.42M

Ticker EVH
Exchange NYSE
Sector Healthcare
Industry Health Information Services
Shares Outstandng 97,063,696
Market Cap $973M
Description
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

Stay updated on Capital Research Global Investors with notifications on news.